Return to content in this issue

 

Compassionate Use of Reslizumab in a Life-threatening Asthma Exacerbation

Granda P1, Villamañán E2,3,4, Heinz S1, Laorden D3,5, Romero D3,6, Añón JM3,7,8, Carpio C3,4,5, Sobrino C2,3, Collada V2,3, Domínguez-Ortega J3,8, Herrero A2,3, Quirce S8, Álvarez-Sala R3,4,5

1Pharmacy Department, Hospital Central de la Defensa Gómez-Ulla, Madrid, Spain
2Pharmacy Department, Hospital Universitario La Paz, Madrid, Spain
3IdiPAZ, Madrid, Spain
4Medicine Department, Universidad Autónoma de Madrid, Spain
5Pulmonology Department, Hospital Universitario La Paz, Madrid, Spain
6Intensive Care Unit, Hospital Universitario La Paz, Instituto de Salud Carlos III, Madrid, Spain
7CIBERES, Instituto de Salud Carlos III, Madrid, Spain
8Allergy Department, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain

J Investig Allergol Clin Immunol 2024; Vol 34(1) : 60-61
doi: 10.18176/jiaci.0920

Key words: Severe asthma, Critical care, Reslizumab